Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
2018
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer
2007
EGFR Antagonists in Cancer Treatment
2008 Standout
Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer
2011
Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
2016
Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer
2014
Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer
2010
Breast cancer
2016 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
2009
The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome
2012
Lung Cancer
2008 Standout
Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes
2017
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
The Z‐shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients
2011
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Targeted treatments in colorectal cancer: state of the art and future perspectives
2010
A Systems Approach for Tumor Pharmacokinetics
2011
Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
2009
Influence of Incubation Time and Sensitizer Localization on Meta-tetra(hydroxyphenyl)chlorin (mTHPC)-Induced Photoinactivation of Cells
2007
Hepatocellular carcinoma
2012 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
2011
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
2014
Colorectal cancer
2013 Standout
Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation Photosensitizer†,‡
2011
An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer
2011
Colorectal cancer
2019 Standout
How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question
2009
The use of combinations of monoclonal antibodies in clinical oncology
2015
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Chemotherapy Maintenance
2016
Nasopharyngeal carcinoma
2015 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
2012
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
2017 Standout
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
Angiogenesis and Vascular Functions in Modulation of Obesity, Adipose Metabolism, and Insulin Sensitivity
2013
Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer
2008
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
2010
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
2011
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
What We Talk About When We Talk About Fat
2014 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
2011
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
2009
A Systematic Review of Oncoplastic Breast-Conserving Surgery
2013
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer
2008
Hepatocellular Carcinoma
2011 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
The role of photodynamic therapy (PDT) physics
2008
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
First international consensus guidelines for breast cancer in young women (BCY1)
2014
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
2012
The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis
2014
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Biomarker-driven and molecular targeted therapies for colorectal cancers
2017
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
2010
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
2008
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
Engineered Proteins Pull Double Duty
2010
Enhancement of the Cytotoxicity and Selectivity of Doxorubicin to Hepatoma Cells by Synergistic Combination of Galactose-Decorated γ-Poly(glutamic acid) Nanoparticles and Low-Intensity Ultrasound
2014
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
2009
Immunotherapy for Colorectal Cancer
2017
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
2008
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Bladder Cancer
2020 Standout
Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
2008
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Boost IORT in Breast Cancer: Body of Evidence
2014
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
BODIPY dyes in photodynamic therapy
2012 Standout
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
2017 Standout
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection.
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma
2015
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Roles for Growth Factors in Cancer Progression
2010
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Photodynamic Therapy in Oncology
2006
Works of Ninja Antonini being referenced
Immunohistochemical categorisation of ductal carcinoma in situ of the breast
2007
Optimizing Meso-Tetra-Hydroxyphenyl-Chlorin–Mediated Photodynamic Therapy for Basal Cell Carcinoma
2006
The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
2010
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
2009
Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation
2008
Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients
2008
Serum Hemoglobin Levels Predict Response to Strontium-89 and Rhenium-186-HEDP Radionuclide Treatment for Painful Osseous Metastases in Prostate Cancer
2006
Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
2006
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
2007
A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity
2008
Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications and Functional Results of Four Different Diversions
2007
Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882
2006
Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin
2013
Optimizing Meso-Tetra-Hydroxyphenyl-Chlorin-Mediated Photodynamic Therapy for Basal Cell Carcinoma
2006
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
2009
Randomized phase III study of capecitabine, oxaliplatin, and bevacizumab with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG)
2008
Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial
2009